Addressing multidrug-resistant tuberculosis in penitentiary hospitals and in the general population of the former Soviet Union

International Journal of Tuberculosis and Lung Disease

Volumn 3, Issue 7, 1999, Pages 582-588

  Portaels, F ^a   Rigouts, L ^a   Bastian, I ^a  

^a INSTITUTE OF TROPICAL MEDICINE   (Belgium)

Author keywords

Multidrug resistant; Prisons; Review; Soviet; Tuberculosis

Indexed keywords

ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ADULT; AGED; FEMALE; HIGH RISK POPULATION; HOSPITAL PATIENT; HUMAN; INDIVIDUALIZATION; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; OUTCOMES RESEARCH; POPULATION RESEARCH; PRIORITY JOURNAL; PRISON; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; REVIEW; RUSSIAN FEDERATION; TUBERCULOSIS;

COMMUNICABLE DISEASE CONTROL; EUROPE; FEMALE; HEALTH STATUS; HOSPITALS, SPECIAL; HUMANS; INCIDENCE; MALE; PRISONS; RISK FACTORS; TUBERCULOSIS, MULTIDRUG-RESISTANT; USSR;

EID: 0032792777     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (42)

1. Antoine D, Schwoebel V, Veen J, Raviglione M, Rieder H L, the national coordinators for tuberculosis in 50 countries of the WHO European Region. Eurosurveillance 1998; 3: 103-107.
2. Raviglione M C, Rieder H L, Styblo K, Khomenko A G, Esteves K, Kochi A. Tuberculosis trends in Eastern Europe and the former USSR. Tubercle Lung Dis 1994; 75: 400-416.
3. Drobniewski F, Tayler E, Ignateko N, et al. Tuberculosis in Siberia: 1. An epidemiological and microbiological assessment. Tubercle Lung Dis 1996; 77: 199-206.
4. Spence D P S, Hotchkiss J, Williams C S D, Davies P D O. Tuberculosis and poverty. BMJ 1993; 307: 759-761.
5. Barr R G, Menzies R. The effect of war on tuberculosis: results of a tuberculin survey among displaced persons in El Salvador and a review of the literature. Tubercle Lung Dis 1994; 75: 251-259.
6. Drobniewski F, Tayler E, Ignatenko N, et al. Tuberculosis in Siberia: 2. Diagnosis, chemoprophylaxis and treatment. Tubercle Lung Dis 1996; 77: 297-301.
7. Coninx R, Pfyffer G E, Mathieu C, et al. Drug resistant tuberculosis in prisons in Azerbaijan case study. BMJ 1998; 316: 1423-1425.
8. Drobniewski F. Tuberculosis in prisons: a forgotten plague. Lancet 1995; 346: 948-949.
9. Maher D, Grzemska M, Coninx R, Reyes H. Guidelines for the control of tuberculosis in prisons. Geneva, Switzerland: World Health Organization; 1998. WHO/TB/98.250.
10. Reyes H, Coninx R. Pitfalls of tuberculosis programmes in prisons. BMJ 1997; 315: 1447-1450.
11. Pablos-Méndez A, Raviglione M C, Laszlo A, et al. Global surveillance for antituberculosis-drug resistance. N Engl J Med 1998; 338: 1641-1649.
12. Portaels F. Multidrug resistant tuberculosis. Eighth International Congress on Infectious Diseases, Boston, USA, May 15-18, 1998. Book of Abstracts No. 25001, p.108.
13. Healing T D, Sakseltseva N A, Banatvala N, et al. Antibiotic resistance among isolates of Mycobacterium tuberculosis from Tomsk region, Western Siberia. Workshop on Multidrug-Resistant Tuberculosis. Proceedings of the Second European Congress on Tropical Medicine, Liverpool, UK, September 14-18, 1998. Abstract No. 459: p 116.
14. Van Embden J D A, Crawford J T, Dale J W, et al. Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standard methodology. J Clin Microbiol 1993; 31: 406-409.
15. Global Tuberculosis Programme. Treatment of tuberculosis: guidelines for national programmes. WHO/TB/97.220. 2nd ed. Geneva, Switzerland: WHO, 1997.
16. Tuberculosis programme: framework for effective tuberculosis control. WHO/TB/94.179. Geneva, Switzerland: WHO, 1994.
17. Crofton J, Chaulet P, Maher D, et al. Guidelines for the management of drug resistant tuberculosis. WHO/TB/96.210. Geneva, Switzerland: WHO, 1997.
18. Kim S J, Hong Y P. Drug resistance of Mycobacterium tuberculosis in Korea. Tubercle Lung Dis 1992; 73: 219-224.
19. Kim S J, Bai G H, Hong Y P. Drug-resistant tuberculosis in Korea, 1994. Int J Tuberc Lung Dis 1997; 1: 302-308.
20. Boulahbal F, Khaled S, Tazir M. The interest of follow-up of resistance of the tubercle bacillus in the evaluation of a programme. Bull Int Union Tuberc Lung Dis 1989; 64(3): 23-25.
21. Zhang L X, Kan G Q, Tu D H, Li J S, Liu X X. Trend of initial drug resistance of tubercle bacilli isolated from new patients with pulmonary tuberculosis and its correlation with the tuberculosis programme in Beijing. Tubercle Lung Dis 1995; 76: 100-103.
22. Farmer P, Kim J Y. Community based approaches to the control of multidrug resistant tuberculosis: introducing "DOTS plus". BMJ 1998; 317: 671-674.
23. Farmer P, Bayona J, Becerra M, et al. The dilemma of MDR-TB in the global era. Int J Tuberc Lung Dis 1998; 2: 869-876.
24. Frieden T R, Fujiwara P I, Washko R M, Hamburg M. Tuberculosis in New York City - turning the tide. N Engl J Med 1995; 333: 229-233.
25. Kaye K, Frieden T R. Tuberculosis control: the relevance of classic principles in an era of acquired immunodeficiency syndrome and multidrug resistance. Epidemiol Rev 1996; 18: 52-63.
26. Mitchison D A, Wallace J G, Bhatia A L, Selkon J B, Subbaiah T V, Lancaster M C. A comparison of the virulence in guinea pigs of South India and British tubercle bacilli. Tubercle 1960; 41: 1-22.
27. Cohn M L, Davis C L. Infectivity and pathogenicity of drug-resistant strains of tubercle bacilli studied by aerogenic infection of guinea pigs. Am Rev Respir Dis 1970; 102: 97-100.
28. Snider D E, Kelly G D, Cauthen G M, Thompson N J, Kilburn J O. Infection and disease among contacts of tuberculosis cases with drug-resistant and drug-susceptible bacilli. Am Rev Respir Dis 1985; 132: 125-132.
29. Kritski A L, Ozorio Marques M J, Rabahi M F, et al. Transmission of tuberculosis to close contacts of patients with multidrug-resistant tuberculosis. Am J Respir Crit Care Med 1996; 153: 331-335.
30. Victor T C, Warren R, Beyers N, van Helden P D. Transmission of multidrug-resistant strains of M. tuberculosis in a high incidence community. Eur J Clin Microbiol Infect Dis 1997; 16: 548-549.
31. Bifani P J, Plikaytis B B, Kapur V, et al. Origin and interstate spread of a New York City multidrug-resistant M. tuberculosis clone family. JAMA 1996; 275: 452-457.
32. Ordway DJ, Sonnenburg M G, Donahue S A, Belisle J T, Orme I M. Drug-resistant strains of Mycobacterium tuberculosis exhibit a range of virulence for mice. Infect Immun 1995; 63: 741-743.
33. Mitchison D A, Nunn A J. Influence of initial drug resistance on the response to short-course chemotherapy of pulmonary tuberculosis. Am Rev Respir Dis 1986; 133: 423-430.
34. Rigouts L, Portaels F. DNA fingerprints of Mycobacterium tuberculosis do not change during the development of resistance to various antituberculosis drugs. Tubercle Lung Dis 1994; 75: 160.
35. Blower S M, Small P M, Hopewell P C. Control strategies for tuberculosis epidemics: new models for old problems. Science 1996; 273: 497-500.
36. Mühlberger F, Nturanye F, Nasbimana J, Portaels F. Ofloxacin-cycloserine-prothionamide-INH combination against treatment refractory lung tuberculosis. Pneumologie 1995; 49: 72-76.
37. Van Deun A, Portaels F. Preliminary results with ofloxacin-containing standard regimens for multidrug resistant TB. Int J Tuberc Lung Dis 1998; 2 (Suppl 2): S374.
38. Park S K, Kim C T, Song S D. Outcome of chemotherapy in 107 patients with pulmonary tuberculosis resistant to isoniazid and rifampicin. Int J Tuberc Lung Dis 1998; 2: 877-884.
39. Foulds J, O'Brien R. New tools for the diagnosis of tuberculosis: the perspective of developing countries. Int J Tuberc Lung Dis 1998; 2: 778-783.
40. Heifets L, Cangelosi G A. Drug susceptibility testing of Mycobacterium tuberculosis - a neglected problem at the turn of the century. Int J Tuberc Lung Dis 1999; 3: 564-581.
41. Rüsch-Gerdes S, Domehl C, Nardi G, Gismondo M R, Welscher H-M, Pfyffer G E. Multicenter evaluation of the Mycobacterial Growth Indicator Tube for testing susceptibility of Mycobacterium tuberculosis to first-line drugs. J Clin Microbiol 1999; 37: 45-48.
42. Frieden T R, Sherman L F, Maw K L, et al. A multi-institutional outbreak of highly drug-resistant tuberculosis: epidemiology and clinical outcomes. JAMA 1996; 276: 1229-1235.